La Jolla Pharmaceutical Company Just Reported And Analysts Have Been Cutting Their Estimates

It’s been a mediocre week for La Jolla Pharmaceutical Company (NASDAQ:LJPC) shareholders, with the stock dropping 12… …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.